Match Document Document Title
5869067 Bi-aromatic compounds and pharmaceutical and cosmetic compositions  
The present invention relates to new aromatic compounds, to their preparation and to their use in human and veterinary medicine and in cosmetic compositions.
5866604 Thiol derivatives with metallopeptidase inhibitory activity  
Compounds of formula (I) wherein R, R 1 , R 2 , R 3 , R 4 , m and n have the meanings reported in the description, processes for their preparation and pharmaceutical compositions which contain them...
5863947 Phenylglycine derivatives useful for treating disorders of the central nervous system  
A pharmaceutical compound of the formula: ##STR1## in which R 1 is hydrogen, hydroxy or C 1 -6 alkoxy, R 2 is hydrogen, carboxy, tetrazolyl, --SO 2 H, --SO 3 H, --OSO 3 H, --CONHOH, or...
5863931 Amidino derivatives and their use as nitric oxide synthase inhibitors  
Amidino derivatives of formula (I) and salts, and pharmaceutically acceptable esters and amides thereof, in which: R 1 is a C 1 -6 straight or branched chain alkyl group, a C 2 -6 alkenyl group, a...
5861431 Incontinence treatment  
The present invention provides a method of treating incontinence in a patient that has a bladder and a urethra. The urethra forms a lumen for draining the bladder. The method comprises the steps of...
5852055 Pharmaceutical compositions comprising paracetamol and L-cysteine or a precursor thereof  
An improved process for the production of a pharmaceutical composition comprising p-hydroxyacetanilide and L-cysteine or a compound which is converted thereto in vivo comprises mixing...
5849335 Composition and method for providing glutamine  
A nutritional composition for providing glutamine to a human or animal. The protein source of the composition includes carob protein which is rich in glutamine. A source of Met may also be...
5843997 Excitatory amino acid receptor antagonists  
The present invention provides novel compounds that affect excitatory amino acid receptors and are useful in the treatment of neurological disorders. This invention also provides synthetic methods...
5833955 Diagnostic tests to assess a persons oral malodor capacity and potential for developing periodontitis  
Oral malodor and periodontitis are common problems affecting a large percentage of the population. The present invention provides a method of assessing an individual's oral malodor producing...
5834517 Meadowfoam sulfosuccinates in personal care applications  
The present invention deals with a process for cleaning and conditioning hair and skin which comprises the contacting of hair or skin woth an effective concentration of certain novel meadowfoam...
5827886 Composition for relief of arthritis-induced symptoms  
A composition and method of using it for ameliorating inflammatory reactions and painful and other symptoms of the diseases of arthritis, lumbago, low back pain, myalgias and neuralgias. The...
5824681 Organic salts of N,N'-diacetyl cystine  
New crystalline organic salts of N,N'-diacetyl cystine with immunomodulating effect, processes for their preparation, pharmaceutical compositions containing them and methods of their...
5821237 Compositions for visually improving skin  
The subject invention relates to compositions which are useful for improving the visual appearance of skin, especially facial skin. The composition contains certain primary actives including at...
5817695 Nutritional product with high fat, low carbohydrate and amino acid imbalance  
A nutritional product is provided for cancer patients comprising, as per caloric requirement, a low concentration of carbohydrate, a high concentration of fat and an imbalance of amino acids...
5807894 Syrup containing N-acetyl-cysteine  
A syrup containing N-acetyl-cysteine, stable for at least two years, having pleasant taste and smell, consists of an aqueous solution of NAC, a sweetening agent and a thickening agent. The solution...
5804582 Method for the treatment of diseases due to defects the immune system  
New crystalline organic salts of N,N'-diacetyl cystine with immunomodulating effect, processes for their preparation, pharmaceutical compositions containing them and methods of their...
5783593 Inhibitors of squalene synthetase and protein farnesyltransferase  
The present invention provides a compound of the formula ##STR1## which inhibit squalene synthetase and cholesterol biosynthesis and are useful in the treatment of e.g., hyperlipidaemia,...
5780508 Pharmacological preparations comprising a cystine derivative  
The invention concerns pharmaceutical preparations for stimulation of the immune system which comprise a cystine derivative as active ingredient.
5776503 Amino acid solutions for treatment of peritoneal dialysis patients  
The present invention provides a dialysis solution that contains amino acids for treating and/or preventing malnutrition in a peritoneal dialysis patient. The amino acid composition is optimized to...
5767119 Method of treating neurodegenerative diseases using an AMPA excitatory amino and an uricosuric agent  
The present invention is a pharmaceutical composition having a combination of an uricosuric agent such as probenecid or the like and an excitatory amino acid antagonist useful for treating a...
5767091 Analgesic effect enhancing preparations  
The present invention provides an analgesic effect enhancing preparation capable of enhancement of the effect of analgesics, the preparation comprising as an active ingredient the following amino...
5767157 Arthritic pain prevention method and compositions  
Disclosed is the method of determining the effectiveness of an agent for the prevention of pain in a person's joints, comprising the steps of a) administering to a susceptible subject a quantity...
5763474 Substituted N-arylmethylamino derivatives of cyclobutene-3,4-diones  
The compounds of the formula: ##STR1## wherein R 1 is straight chain alkyl, branched chain alkyl cycloalkyl, hydroxyalkyl, fluoroalkyl or polyfluoroalkyl; R 2 and R 3 are, independently,...
5763481 Vinylcarboxylic acid derivatives  
Compounds of the formula ##STR1## wherein R 1 is C 3 -C 8 cycloalkyl, halo-C 3 -C 8 cycloalkyl, C 3 -C 8 cycloalkyl-C 1 -C 6 alkyl, halo-C 3 -C 8 cycloalkyl-C 1 -C 6 alkyl, --Si(R 3 )...
5756545 Biphenysulfonamide matrix metal alloproteinase inhibitors  
Compounds of the formula ##STR1## wherein R 1 includes alkyl, halo, nitro, amino, cyano, alkoxy, and alkoxycarbonyl; R 2 is alkyl and substituted alkyl; and R 3 is OH or NHOH are useful for...
5739163 Aromatic compounds containing basic and acidic termini useful as fibrinogen receptor antagonists  
This invention relates to novel compounds containing basic and acidic termini, pharmaceutical compositions containing such compounds, processes for preparing such compounds, and to methods of using...
5733539 Bait for fishes and shellfishes  
The invention discloses a bait for fishes and shellfishes characterized in that the bait comprises a matrix material containing a microorganically fermented product of a plant residue obtained by...
5733909 Diphenyl stilbenes as prodrugs to COX-2 inhibitors  
The invention encompasses the novel compound of Formula I useful in the treatment of cyclooxygenase-2 mediated diseases. ##STR1## The invention also encompasses certain pharmaceutical compositions...
5728736 Reduction of hair growth  
Mammalian hair growth is reduced by applying to the skin a dermatologically acceptable composition including an inhibitor of arginase.
5726165 Derivatives of 4-(2-aminoethyl)phenoxymethyl-phosphonic and -phosphinic acid and pharmaceutical and veterinary uses therefor  
A compound of formula (I): ##STR1## or a pharmaceutically acceptable salt, or solvate thereof, wherein, R o represents an aryl group, optionally substituted; X represents O or S; R 1 and...
5723493 Naphthyloxyacetic acid  
(1) Naphthyloxyaetic acid represented by the compound of the formula (I): ##STR1## and non-toxic salts thereof, (2) process for the preparation of the compounds represented by the compound of the...
5716990 Drug delivery systems  
Nitrogen mustard pro-drugs of the formula ##STR1## are disclosed where R is the residue of an α-amino acid RNH 2 and M is a disubstituted amino "mustard" group, useful in antibody directed enzyme...
5712309 Composition for treatment of hangovers  
A composition for reducing the symptoms of hangover, including therapeutically effective amounts of L-methionine and L-alanine, or pharmaceutically acceptable salts thereof as active ingredients.
5708029 High blood pressure relief method and compositions  
Disclosed is the method of determining the effectiveness of an agent for the relief of elevation of the blood pressure, comprising the steps of a) administering to a susceptible subject a...
5703127 Composition, dosage unit, and method for treating stomach disorders  
A dosage unit for treating stomach disorders, comprises an effective dosage of L- or DL-Methionine, and an effective dosage of a sweetener.
5696164 Antifungal treatment of nails  
There is disclosed a method for the treatment of fungal diseases in nails, which comprises the topical administration to the nail and, if desired, also to the surrounding skin, of (1) a sulfhydryl...
5691381 Hydroxamic and carbocyclic acids as metalloprotease inhibitors  
The present invention provides novel hydroxamic acids and carbocyclic acids and derivatives thereof and to pharmaceutical compositions and methods of use of these novel compounds for the inhibition...
5691380 Stable n-acetylcysteine compositions and methods for treating human skin therewith  
The present invention relates to topical compositions comprising N-acetylcysteine demonstrating improved odor stability. These compositions are useful for treating and visibly improving the...
5690967 Compositions for improved topical delivery of lactic acid  
Compositions for improved topical delivery of lactic acid comprising lactic acid and an amphoteric or pseudoamphoteric agent.
5686492 Disubstituted p-fluorobenzenesulfonamides  
Described herein are disubstituted p-fluorobenzenesulfonamides, containing a CF 3 group, of general formula I ##STR1## which are suitable as NMR diagnostic agents.
5663208 Antifungal wound healing compositions and methods for preparing and using same  
This invention pertains to therapeutic antifungal-wound healing compositions. The compositions comprise a therapeutically effective amount of an antifungal agent and a wound healing compositions....
5658957 Immunostimulating wound healing compositions and method for preparing and using same  
This invention pertains to therapeutic immunostimulating-wound healing compositions. The compositions comprise a therapeutically effective amount of an immunostimulating agent and a wound healing...
5658943 Phenylalanine derivatives as endothelin antagonists  
Novel antagonists of endothelin are described, as well as novel intermediates used in their preparation, methods for the preparation and pharmaceutical compositions of the same, which are useful in...
5652274 Therapeutic-wound healing compositions and methods for preparing and using same  
This invention pertains to therapeutic wound healing compositions for protecting and resuscitating mammalian cells. In one embodiment, the therapeutic wound healing composition comprises (a)...
5650418 Therapeutic lysine salt composition and method of use  
A therapeutic lysine-based composition and methods for its use in the prevention and treatment of cardiovascular disease is disclosed. The composition includes at least one ascorbate compound,...
5650428 Arylsulfonamide derivative and pharmaceutical compositions and use thereof  
An arylsulfonamide derivative of the formula (I): ##STR1## wherein R 1 is unsubstituted phenyl or naphthyl, or phenyl substituted by 1 to 3 same or different substituents selected from the group...
5648393 Treatment of male impotence with s-nitrosylated compounds  
Methods of relaxing corpus cavernosum smooth muscle, treating disease states responsive to prevention or relaxation of undesirable contractions of corpus cavernosum smooth muscle and of treating...
5646177 Glutathione derivatives of anthracyclines  
Disclosed herein are new anthracyclines which are derived from conjugation with glutathione, for example from conjugation of adriamycin, daunomycin and menogaril with glutathione: compounds 7 I, 7...
5637616 Method for treating diseases mediated by proteases  
A method for the topical or systemic treatment of disorders mediated by proteases which result in skin or mucosal lesions, and in particular, pemphigus, cicatricial pemphigoid, bullous pemphigoid,...
5629343 N-(mercaptoacyl) peptidyl derivatives as antidegenerative agents  
Novel N-(mercaptoacyl)peptidyl compounds are useful as inhibitors of matrix metalloendoproteinases which degrade major components of articular cartilage and basement membranes causing degenerative...